PAR 12.7% 31.0¢ paradigm biopharmaceuticals limited..

PAR & MPS, page-5

  1. 253 Posts.
    lightbulb Created with Sketch. 33
    Bene didnt have the research or capital to go through phase 2-3 trials or OA ?
    Didnt see the potential in re purposing it as an injectable solution for a better result ?
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.